Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Demasi

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Hospital Practice (1995)|January 15, 1996
A man with "shrub leg"R DeMasi, M Brown
The American Journal of the Medical Sciences|April 1, 1996
Case report: penicillin-resistant pneumococcal meningitis: navigating a therapeutic minefieldG S Greene, R Demasi
Antiviral Therapy|February 22, 2000
Meta-analysis of antiretroviral effects on HIV-1 RNA, CD4 cell count and progression to AIDS or deathA M Hill, R DeMasi, D Dawson
AIDS (London, England)|April 16, 1998
The effects of lamivudine treatment on HIV-1 disease progression are highly correlated with plasma HIV-1 RNA and CD4 cell countJ S Montaner, R DeMasi, A M Hill
The Journal of Arthroplasty|December 1, 1994
A prospective study of a titanium femoral component for cemented total hip arthroplastyG S Tompkins, P F Lachiewicz, R DeMasi
Clinical Orthopaedics and Related Research|September 1, 1993
Survivorship analysis of cemented high modulus total hip arthroplastyJ A Bosco, P F Lachiewicz, R DeMasi
The Journal of Arthroplasty|December 1, 1992
A prospective study of 100 consecutive Harris-Galante porous total hip arthroplasties. 2-5-year resultsP F Lachiewicz, W E Anspach, R DeMasi
Antiviral Therapy|February 22, 2000
Prediction of HIV-1 RNA suppression and its durability during treatment with zidovudine/lamivudineM Opravil, A M Hill, R DeMasi, et al.
The Journal of Infectious Diseases|November 17, 1998
Variability in repeated consecutive measurements of plasma human immunodeficiency virus RNA in persons receiving stable nucleoside reverse transcriptase inhibitor therapy or no treatmentJ A Bartlett, R DeMasi, D Dawson, et al.
AIDS (London, England)|November 14, 1998
HIV-1 RNA, CD4 cell count and the risk of progression to AIDS and death during treatment with HIV-1 reverse transcriptase inhibitorsS Staszewski, R DeMasi, A M Hill, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Hospital Practice (1995)|January 15, 1996
A man with "shrub leg"R DeMasi, M Brown
The American Journal of the Medical Sciences|April 1, 1996
Case report: penicillin-resistant pneumococcal meningitis: navigating a therapeutic minefieldG S Greene, R Demasi
Antiviral Therapy|February 22, 2000
Meta-analysis of antiretroviral effects on HIV-1 RNA, CD4 cell count and progression to AIDS or deathA M Hill, R DeMasi, D Dawson
AIDS (London, England)|April 16, 1998
The effects of lamivudine treatment on HIV-1 disease progression are highly correlated with plasma HIV-1 RNA and CD4 cell countJ S Montaner, R DeMasi, A M Hill
The Journal of Arthroplasty|December 1, 1994
A prospective study of a titanium femoral component for cemented total hip arthroplastyG S Tompkins, P F Lachiewicz, R DeMasi
Clinical Orthopaedics and Related Research|September 1, 1993
Survivorship analysis of cemented high modulus total hip arthroplastyJ A Bosco, P F Lachiewicz, R DeMasi
The Journal of Arthroplasty|December 1, 1992
A prospective study of 100 consecutive Harris-Galante porous total hip arthroplasties. 2-5-year resultsP F Lachiewicz, W E Anspach, R DeMasi
Antiviral Therapy|February 22, 2000
Prediction of HIV-1 RNA suppression and its durability during treatment with zidovudine/lamivudineM Opravil, A M Hill, R DeMasi, et al.
The Journal of Infectious Diseases|November 17, 1998
Variability in repeated consecutive measurements of plasma human immunodeficiency virus RNA in persons receiving stable nucleoside reverse transcriptase inhibitor therapy or no treatmentJ A Bartlett, R DeMasi, D Dawson, et al.
AIDS (London, England)|November 14, 1998
HIV-1 RNA, CD4 cell count and the risk of progression to AIDS and death during treatment with HIV-1 reverse transcriptase inhibitorsS Staszewski, R DeMasi, A M Hill, et al.
Pageof 3